Xiang Li Ph.D Overview
- Firm
- Heda Ventures
- Primary Position
-
Managing Partner
Xiang Li Ph.D General Information
Biography
Mr. Xiang Li served as Managing Partner at Heda Ventures. He earned a PhD from the Chinese Academy of Science, and worked as a postdoctoral fellow at UC Berkeley. He is the member of Chinese "Thousand of People Plan". Dr Li is the founder and chairman of Peptide Biomedical limited company (acquired by Xinbang Pharmaceutical Co., Ltd.) and the Chairman of Xinbang Pharmaceutical Co., Ltd. (SHE: 002390). He was the first Chinese student in US, who established biomedical and peptide company in Silicon Valley. He also established the first and the largest peptide company in China that provides service outsourcing, diagnostic testing products and peptide drug R&D. He led the team and passed 4 FDA inspections without any error.
Contact Information
Xiang Li Ph.D FAQs
-
Who is Xiang Li Ph.D?
Mr. Xiang Li served as Managing Partner at Heda Ventures.
-
How much does Xiang Li Ph.D typically invest?
Xiang Li Ph.D's median deal size is .
-
What is Xiang Li Ph.D’s main position?
Xiang Li Ph.D’s primary position is Managing Partner.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
